Novel treatments for inflammatory bowel disease
Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
Korean J Intern Med. 2018;33(1):20-27.   Published online 2017 Dec 11     DOI: https://doi.org/10.3904/kjim.2017.393
Citations to this article as recorded by Crossref logo
High‐dimensional single‐cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitis
Sebastian Fuchs, Nadia Sawas, Nicolas Staedler, David A. Schubert, Annalisa D'Andrea, Robert Zeiser, Luca Piali, Petr Hruz, Andreas P. Frei
European Journal of Immunology.2019; 49(3): 462.     CrossRef
Zeaxanthin exerts protective effects on acetic acid-induced colitis in rats via modulation of pro-inflammatory cytokines and oxidative stress
Gehan El-Akabawy, Neveen M. El-Sherif
Biomedicine & Pharmacotherapy.2019; 111: 841.     CrossRef
Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
Caifang Gao, Lijuan Liu, Yangyang Zhou, Zhaoxiang Bian, Shengpeng Wang, Yitao Wang
Chinese Medicine.2019;[Epub]     CrossRef
Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer—a Critical Review
Adrian Szczepaniak, Jakub Fichna
Biomolecules.2019; 9(9): 398.     CrossRef
Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East
Ala I Sharara, Samir Al Awadhi, Othman Alharbi, Hisham Al Dhahab, Mohamed Mounir, Leonardo Salese, Ena Singh, Nancy Sunna, Nadine Tarcha, Mahmoud Mosli
Expert Review of Gastroenterology & Hepatology.2018; 12(9): 883.     CrossRef
Impact of Modern Drug Therapy on Surgery: Ulcerative Colitis
Florian Kuehn, Richard A. Hodin
Visceral Medicine.2018; 34(6): 426.     CrossRef